Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Securities Case

Investors have until January 5 to seek appointment as lead plaintiff in the Minnesota class action over the Inspire V rollout.

Overview

A federal securities class action against Inspire Medical Systems is pending in the District of Minnesota, captioned City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 0:25-cv-04247.
The case targets statements made from August 6, 2024 through August 4, 2025 regarding market demand for the Inspire V device and the company’s readiness to commercialize it.
On August 4, 2025, Inspire disclosed a longer-than-expected rollout and cut its 2025 EPS guidance by more than 80%, citing incomplete training and onboarding at implanting centers and claims-processing software updates that took effect July 1, 2025.
The stock fell about $42.04, or more than 32%, from $129.95 on August 4, 2025 to $87.91 on August 5, 2025 following the disclosure.
Bleichmar Fonti & Auld, the Rosen Law Firm, and Kuehn Law are recruiting investors, with Kuehn also probing potential fiduciary-duty issues including SleepSync IT approvals and reimbursement coding, and no class has been certified.